EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, China Health Group's enterprise value is HK$472.83 Mil.
China Health Group's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was HK$-26.85 Mil. Therefore, China Health Group's EV-to-EBITDA for today is -17.61.
The historical rank and industry rank for China Health Group's EV-to-EBITDA or its related term are showing as below:
HKSE:00673'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -223.23 Med: -8.61 Max: 2.46
Current: -16.89
During the past 13 years, the highest EV-to-EBITDA of China Health Group was 2.46. The lowest was -223.23. And the median was -8.61.
HKSE:00673's EV-to-EBITDA is ranked worse than 100% of 81
companies
in the Medical Distribution industry
Industry Median: 10.18
vs HKSE:00673: -16.89
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
China Health Group EV-to-EBITDA Historical Data
The historical data trend for China Health Group's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of China Health Group's EV-to-EBITDA
For the Medical Distribution subindustry, China Health Group's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Health Group's EV-to-EBITDA Distribution in the Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, China Health Group's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where China Health Group's EV-to-EBITDA falls into.
China Health Group's current Enterprise Value is HK$472.83 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. China Health Group's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was HK$-26.85 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Health Group (HKSE:00673) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
China Health Group's PE Ratio for today is calculated as:
China Health Group's share price for today is HK$0.98.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. China Health Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was HK$-0.065.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of China Health Group's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
China Health Group (HKSE:00673) Business Description
China Health Group Ltd is an investment holding company. It is principally engaged in the distribution and service of medical equipment and consumables, provision of hospital operation and management service, and business factoring. It operates in the business in three segments Distribution and service in medical equipment and consumables; Hospital operation and management services and Business factoring service. It derives a majority of revenue from the Distribution and service in the medical equipment and consumables segment. Geographically the group's locations are located in the PRC.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:00673 has been successfully added to your 